| P2093 | author name string | F Salerno | |
| | M Cazzaniga | |
| | G Borroni | |
| | B Omazzi | |
| | M Andreoletti | |
| | N Terreni | |
| | P Guerzoni | |
| | R Ceriani | |
| | A Prada | |
| | G Spinzi | |
| | M G L Pich | |
| P2860 | cites work | Evidence that plasma concentration rather than dose per kilogram body weight predicts ribavirin-induced anaemia | Q44738462 |
| | Factors contributing to ribavirin dose reduction due to anemia during interferon alfa2b and ribavirin combination therapy for chronic hepatitis C. | Q45006616 |
| | Factors contributing to ribavirin-induced anemia | Q45105371 |
| | Assessment of adverse reactions and pharmacokinetics of ribavirin in combination with interferon alpha-2b in patients with chronic hepatitis C. | Q50579747 |
| | Peginterferon alfa-2a plus ribavirin for chronic hepatitis C virus infection | Q27860901 |
| | Peginterferon alfa-2b plus ribavirin compared with interferon alfa-2b plus ribavirin for initial treatment of chronic hepatitis C: a randomised trial | Q27860949 |
| | Hemolytic anemia induced by ribavirin therapy in patients with chronic hepatitis C virus infection: role of membrane oxidative damage | Q28374338 |
| | Peginterferon-alpha2a and ribavirin combination therapy in chronic hepatitis C: a randomized study of treatment duration and ribavirin dose | Q29547886 |
| | A more accurate method to estimate glomerular filtration rate from serum creatinine: a new prediction equation. Modification of Diet in Renal Disease Study Group | Q29614889 |
| | The prevalence of hepatitis C virus infection in the United States, 1999 through 2002 | Q29619974 |
| | Assessing kidney function--measured and estimated glomerular filtration rate | Q34535861 |
| | Telaprevir with peginterferon and ribavirin for chronic HCV genotype 1 infection | Q34607097 |
| | Review article: renal function assessment in cirrhosis - difficulties and alternative measurements | Q36945081 |
| | Chronic kidney disease: a public health priority and harbinger of premature cardiovascular disease | Q37784542 |
| | The importance of HCV on the burden of chronic liver disease in Italy: a multicenter prevalence study of 9,997 cases. | Q40445497 |
| | Prevalence, risk factors, and genotype distribution of hepatitis C virus infection in the general population: a community-based survey in southern Italy | Q42984982 |
| | Peginterferon alpha-2a (40 kDa) and ribavirin: comparable rates of sustained virological response in sub-sets of older and younger HCV genotype 1 patients | Q42988204 |
| | Hepatitis C virus treatment-related anemia is associated with higher sustained virologic response rate | Q42999332 |
| | Early decline of hemoglobin correlates with progression of ribavirin-induced hemolytic anemia during interferon plus ribavirin combination therapy in patients with chronic hepatitis C. | Q43032538 |
| | Virological response is associated with decline in hemoglobin concentration during pegylated interferon and ribavirin therapy in hepatitis C virus genotype 1. | Q43035939 |
| | The effect of age on response to therapy with peginterferon alpha plus ribavirin in a cohort of patients with chronic HCV hepatitis including subjects older than 65 yr. | Q43036906 |
| | Interferon and ribavirin treatment in patients with hepatitis C-associated renal disease and renal insufficiency | Q43047381 |
| | Changes in haemoglobin during interferon alpha-2b plus ribavirin combination therapy for chronic hepatitis C virus infection. | Q43586612 |
| | Factors influencing ribavirin-induced hemolysis | Q43672293 |
| | Dosage of ribavirin in patients with hepatitis C should be based on renal function: a population pharmacokinetic analysis. | Q44228676 |
| P433 | issue | 4 | |
| P921 | main subject | ribavirin | Q421862 |
| P304 | page(s) | e90-5 | |
| P577 | publication date | 2012-10-22 | |
| P1433 | published in | Journal of Viral Hepatitis | Q15749962 |
| P1476 | title | Low glomerular filtration rate is a risk factor for ribavirin-associated anaemia in old patients with chronic hepatitis C. | |
| P478 | volume | 20 | |